Ocugen (OCGN) announces FDA has issued clinical hold on IND to evaluate the COVID-19 vaccine candidate, COVAXIN

Go back to Ocugen (OCGN) announces FDA has issued clinical hold on IND to evaluate the COVID-19 vaccine candidate, COVAXIN
(NASDAQ: OCGN) Delayed: 1.29 +0.05 (4.03%)
Previous Close $1.24    52 Week High
Open $1.27    52 Week Low
Day High $1.33    P/E N/A 
Day Low $1.26    EPS
Volume 6,213,218